In 2007, the University of Queensland Diamantina Institute was established as the sixth research institute of The University of Queensland. The Institute was formed through the amalgamation of UQ's Centre for Immunology and Cancer Research (CICR) and the Centre for Diabetes and Endocrinology Research (CDER). UQDI has grown to include over 300 researchers, students and support staff.In our short time, we have made major contributions to science. Amongst UQDI’s achievements are: Discovery, development and release of the world’s first cervical cancer vaccine. Clinical trials of the vaccine program in developing countries. Identification of genes responsible for one-third of the risk of developing ankylosing spondylitis. Development of a new test to identify patients with the potential to develop diabetes. Design of one the first needle-free vaccine technologies. Discovery of gene-silencing technology for cancer treatment. Identification of new genes involved in multiple sclerosis.